Tailwind Biotech ApS
Private limited companyCVR 43630938TaastrupActive
Tailwind Biotech ApS is a private limited company, based in Taastrup, active in research and experimental development on natural sciences and engineering, founded in 2022. Equity was negative at the end of 2025 (−DKK 32,297). The company made a loss in both 2024 and 2025, most recently DKK 41,518.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 25% (2024 → 2025), to DKK 637k.
- The loss grew: from DKK 26,662 to DKK 41,518 (2024 → 2025).
- Equity turned negative: −DKK 32,297 (2024 → 2025).
Employees
- 1 fewer employees than a year earlier: 2 (05/2026) against 3 (05/2025).
Registrations, last 24 months
- 02/09/2026: Moved to Blåkildevej 9, 2630 Taastrup
- 31/07/2026: Moved to Matthæusgade 50, 4. 31, 1666 København V
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | 322 | 853 | 637 | −25.3% |
| Operating profit (EBIT) | – | −45 | −60 | −33.4% |
| Profit before tax | −9 | −47 | −62 | −31.5% |
| Net profit | −4 | −27 | −42 | −55.7% |
| Total assets | 68 | 49 | 24 | −50.9% |
| Equity | 36 | 9 | −32 | −450.3% |
| Liabilities | 32 | 39 | 56 | +42.8% |
| Cash and cash equivalents | 53 | 28 | 0 | −100% |
| Average number of employees | 1 | 3 | 0 | −100% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 32,297 at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 02/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 09/04/2025 | The company | PDFXBRL |
| 2023 | 01/11/2022 – 31/12/2023 | 25/03/2024 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 51,707of 69,742 Better than 26% | No. 60,971of 69,964 Better than 13% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 136of 323 Better than 58% | No. 221of 329 Better than 33% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 11,165of 16,614 Better than 33% | No. 13,368of 16,661 Better than 20% |
| All companies of type ApS66,508 companies in the comparison | No. 49,754of 66,379 Better than 25% | No. 57,287of 66,505 Better than 14% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Tailwind Biotech ApSDKK 637k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Tailwind Biotech ApS−DKK 41,518
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Tailwind Biotech ApS−DKK 32,297
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Tailwind Biotech ApS2
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- CTW Holding ApS25%
- HT Simonsen Holding ApS10%
- LCAR Holding ApS25%
- MC44 Holding ApS25%
Management
3 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Christopher Thomas Workman | Director | 01/11/2022 |
| Lorenzo Carvelli | Director | 01/11/2022 |
| Mirko Ceriani | Director | 01/11/2022 |
- Founders
- HT Simonsen Holding ApS, CTW Holding ApS, KRRM Holding ApS, LCAR Holding ApS, MC44 Holding ApS
Signing rule: Virksomheden tegnes af den samlede direktion.
Address and production units
1 active production unitsBlåkildevej 9
2630 Taastrup
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Tailwind Biotech ApS | Blåkildevej 9, 2630 Taastrup | 2 | 1028731627 |
Purpose
Virksomhedens formål er at drive virksomhed baseret på anvendelse af kunstig intelligens indenfor bioteknologi samt anden hermed beslægtet virksomhed efter ledelsens skøn.
The purpose is quoted from the register in Danish.
Changes year by year
22 registered events20263 changesaddress 2 · accounts 1
- AddressMoved to Blåkildevej 9, 2630 Taastrup
- AddressMoved to Matthæusgade 50, 4. 31, 1666 København V
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20237 changesownership 7
- OwnershipHT Simonsen Holding ApS registered as owner (10%)
- OwnershipLCAR Holding ApS registered as owner (25%)
- OwnershipMC44 Holding ApS registered as owner (25%)
- OwnershipKRRM Holding ApS is no longer registered as owner
- OwnershipMC44 Holding ApS is no longer registered as owner
- OwnershipHT Simonsen Holding ApS is no longer registered as owner
- OwnershipLCAR Holding ApS is no longer registered as owner
20229 changesfounded 1 · management 3 · ownership 5
- FoundedRegistered as Tailwind Biotech ApS
- ManagementChristopher Thomas Workman appointed director
- ManagementLorenzo Carvelli appointed director
- ManagementMirko Ceriani appointed director
- OwnershipMC44 Holding ApS registered as owner (15%)
- OwnershipHT Simonsen Holding ApS registered as owner (15%)
- OwnershipCTW Holding ApS registered as owner (25%)
- OwnershipKRRM Holding ApS registered as owner (20%)
- OwnershipLCAR Holding ApS registered as owner (15%)
Related companies
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.